Long-Term Management of Gastrointestinal Spasms with Dicyclomine

Introduction to Dicyclomine and Hyoscine Butylbromide

Dicyclomine can be used for long-term management of gastrointestinal spasms, but hyoscine butylbromide (administered intramuscularly) is preferred for chronic use due to better tolerability and reduced central nervous system effects, as recommended by the American Gastroenterological Association 1, 2

Dicyclomine hydrochloride is a tertiary amine antimuscarinic agent with less marked anticholinergic action than atropine and may have direct smooth muscle relaxant properties, according to the American College of Gastroenterology 1, 2

Hyoscine butylbromide (quaternary ammonium compound) is specifically advocated for long-term home use because it has less lipid solubility than dicyclomine, reducing blood-brain barrier penetration, and has fewer central nervous system effects, as noted by the Gut guidelines 1, 2
Hyoscine butylbromide can be used long-term at home via intramuscular route, with poorly absorbed oral preparations making intramuscular preparations more effective for chronic administration, as recommended by the American Gastroenterological Association 1, 2

The Gut guidelines specifically note that anticholinergics, such as dicyclomine, are contraindicated in post-bowel anastomosis patients 3
The American Gastroenterological Association recommends that drug therapy should target the patient's most bothersome symptom, justifying long-term dicyclomine use when abdominal pain/spasm is the predominant issue, even if other symptoms exist 3

The American Gastroenterological Association (AGA) suggests using antispasmodics like dicyclomine in patients with irritable bowel syndrome (IBS) (conditional recommendation, low certainty in evidence) 4
Dicyclomine is commonly used to reduce abdominal pain associated with IBS 4, 5
Antispasmodics provide adequate global relief of IBS symptoms compared to placebo (RR, 0.67; 95% CI, 0.55–0.80) 4
Antispasmodics demonstrate improvement in abdominal pain compared to placebo (RR, 0.74; 95% CI, 0.59–0.93) 5

Most common adverse events include dry mouth, dizziness, and blurred vision due to anticholinergic effects 4, 6
Regular use in constipation-predominant conditions may be limited due to its anticholinergic effects 5
Anticholinergic side effects may limit use in some patients 6